Published in
Springer, Investigational New Drugs, 4(34), p. 481-489, 2016
DOI: 10.1007/s10637-016-0364-5
Links
Tools
A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer
Journal article published in 2016 by
Paul L. Swiecicki,
Emily Bellile,
Assuntina G. Sacco,
Alexander T. Pearson,
Jeremy M. G. Taylor,
Trachette L. Jackson,
Douglas B. Chepeha,
Matthew E. Spector,
Andrew Shuman,
Kelly Malloy,
Jeffrey Moyer,
Erin McKean 
,
Scott McLean,
Ammar Sukari,
Gregory T. Wolf
and other authors.
,
Scott McLean,
Ammar Sukari,
Gregory T. Wolf
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 